iShares Neuroscience and Healthcare ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.47
資產淨值: 604.09
成立日期: 24/08/2022
 
分析
市值分佈:
60.12%
大市值
22.17%
中市值
13.76%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 25/04/2026 06:03) 總持有投資項目: 67  
0%
 
100%
     10大 (41.62%)
代號 名稱 佔比% 持有日期
XENEXenon Pharmaceuticals5.2231/03/2026
ALKSAlkermes plc4.6331/03/2026
CNTACentessa Pharmaceuticals plc4.1831/03/2026
SRRKScholar Rock Holding Corp4.0731/03/2026
PTCTPTC Therapeutics4.0731/03/2026
ARWRArrowhead Pharmaceuticals3.9531/03/2026
AXSMAxsome Therapeutics3.9331/03/2026
PRAXPraxis Precision Medicines3.8931/03/2026
NBIXNeurocrine Biosciences3.8731/03/2026
ARGXargenx SE3.8131/03/2026
ACADACADIA Pharmaceuticals3.7731/03/2026
BIIBBiogen3.7431/03/2026
DNTHDianthus Therapeutics3.4131/03/2026
SUPNSupernus Pharmaceuticals3.1531/03/2026
DNLIDenali Therapeutics3.0431/03/2026
CPRXCatalyst Pharmaceuticals3.0431/03/2026
EWTXEdgewise Therapeutics2.7131/03/2026
DYNDyne Therapeutics2.5631/03/2026
SRPTSarepta Therapeutics2.4231/03/2026
AXGNAxogen1.8831/03/2026
 1    2    3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.